02137.HK
Brii Biosciences Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.98
+1.03%Margins
Gross margin
63.1%
EBITDA margin
-1440.8%
EBIT margin
-1478.3%
Net margin
-918.1%
FCF margin
-1351.4%
-7.6%
Return on equity
-7.6%
Return on assets
-12.2%
Return on invested capital
0.01x
Asset turnover
-HKD 277.3M
Cash from operations
HKD 2.88
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026